April 24, 2024

Exploring Risk of Endophthalmitis With Intravitreal Injections

By Sruthi Arepalli, MD

October 1, 2023

SUBSPECIALTY NEWS: Biosimilar FDA application hits roadblock, Apellis provides guidance on Syfovre use, and more.

By Rochelle Nataloni, contributing writer

January 1, 2023

Clinical Trial Update January/February 2023

March 1, 2022

Intraocular Inflammation Associated With Current and Prospective Therapies for Patients With Wet AMD

By Andreas M. Wingert, Jayanth Sridhar, MD